Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Rodriguez-Barrueco

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Science Advances|June 26, 2026
METTL3 regulates exocytosis independently of m<sup>6</sup>AMargalida Esteva-Socias, Devi Prasad Bhattarai, Cyrinne Achour, et al.
Breast Cancer Research : BCR|April 21, 2017
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Breast Cancer Research : BCR|December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Cancer Cell|September 15, 2012
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cellsJosep Domingo-Domenech, Samuel J Vidal, Veronica Rodriguez-Bravo, et al.
Genes & Development|August 1, 2015
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancersRuth Rodriguez-Barrueco, Jiyang Yu, Laura P Saucedo-Cuevas, et al.
Cell Research|April 9, 2014
Double-stranded DNA in exosomes: a novel biomarker in cancer detectionBasant Kumar Thakur, Haiying Zhang, Annette Becker, et al.
Cell|January 24, 2012
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayWilliam A Freed-Pastor, Hideaki Mizuno, Xi Zhao, et al.
Cancer Cell|February 12, 2015
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancerSamuel J Vidal, Veronica Rodriguez-Bravo, S Aidan Quinn, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Cancer Discovery|March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk NeuroblastomaPresha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Science Advances|June 26, 2026
METTL3 regulates exocytosis independently of m<sup>6</sup>AMargalida Esteva-Socias, Devi Prasad Bhattarai, Cyrinne Achour, et al.
Breast Cancer Research : BCR|April 21, 2017
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Breast Cancer Research : BCR|December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Cancer Cell|September 15, 2012
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cellsJosep Domingo-Domenech, Samuel J Vidal, Veronica Rodriguez-Bravo, et al.
Genes & Development|August 1, 2015
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancersRuth Rodriguez-Barrueco, Jiyang Yu, Laura P Saucedo-Cuevas, et al.
Cell Research|April 9, 2014
Double-stranded DNA in exosomes: a novel biomarker in cancer detectionBasant Kumar Thakur, Haiying Zhang, Annette Becker, et al.
Cell|January 24, 2012
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayWilliam A Freed-Pastor, Hideaki Mizuno, Xi Zhao, et al.
Cancer Cell|February 12, 2015
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancerSamuel J Vidal, Veronica Rodriguez-Bravo, S Aidan Quinn, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Cancer Discovery|March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk NeuroblastomaPresha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.
Pageof 3